Low Load Blood Flow Restriction Resistance Training in Colorectal Cancer Related Sarcopenia
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
PURPOSE: To investigate the effects of low-load resistance training combined with blood flow restriction on muscle strength, functional performance, and cancer-related fatigue in colorectal cancer survivors with probable sarcopenia. BACKGROUND: Muscle weakness and cancer-related fatigue are prevalent in colorectal cancer survivors with probable sarcopenia and are associated with adverse outcomes (Brown et al., 2022; Caan et al., 2018). High-load resistance training is often poorly tolerated in this population (Schmitz et al., 2019). Although low-load resistance training with blood flow restriction shows promise, CRC-specific randomized evidence remains limited (Patterson et al., 2019; Arnold et al., 2017). HYPOTHESES: It is hypothesized that low-load blood flow restriction resistance training will lead to significant improvements in muscle strength and functional performance, and a significant reduction in cancer-related fatigue in colorectal cancer survivors with probable sarcopenia. RESEARCH QUESTION: Does low-load blood flow restriction resistance training will lead to significant improvements in muscle strength and functional performance, and a significant reduction in cancer-related fatigue in colorectal cancer survivors with probable sarcopenia?
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Diagnoza raka jelita grubego ze słabością mięśni
- •Wiek 40-59 lat
- •Słaba siła mięśni (potwierdzzona testem wstawania z krzesła ponad 15 sekund)
- •Aktualnie w trakcie chemioterapii/radioterapii lub po operacji, w stabilnym stanie zdrowia
- •Zatwierdzenie lekarza do udziału w ćwiczeniach nadzorowanych
- •Zdolność do wykonywania poleceń i ukończenia testów
✗ Disqualifies
- •Przeciwwskazania do ćwiczeń siłowych lub ograniczenia przepływu krwi
- •Niekontrolowana choroba serca lub wysokie ciśnienie krwi
- •Niedawne zakrzepy krwi lub zatory
- •Poważne choroby naczyń w nogach
- •Niekontrolowane powikłania leczenia (np. ciężka anemia lub infekcja)
- •Przerzuty raka do kości w dolnych kończynach
- •Zaburzenia neurologiczne lub mięśniowo-szkieletowe uniemożliwiające bezpieczny udział
Simplified criteria — AI translation
Trial details
- Minimum age
- 40 Years
- Maximum age
- 59 Years
- Last updated (source)
- October 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Private Clinics
Cairo, Egypt
Trial contact
Ahmed Adel Radwan, MSc
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.